• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

快速评估体外扩增的人调节性 T 细胞功能。

Rapid assessment of in vitro expanded human regulatory T cell function.

机构信息

BD Biosciences, 2350 Qume Drive, San Jose, CA 95131, USA.

出版信息

J Immunol Methods. 2011 Sep 30;372(1-2):95-106. doi: 10.1016/j.jim.2011.07.001. Epub 2011 Jul 18.

DOI:10.1016/j.jim.2011.07.001
PMID:21781972
Abstract

Human regulatory T cells (Treg) are able to actively suppress autoreactive immune responses. Phenotypically, they are broadly characterized as CD4+, CD25+, CD127(lo/⁻) and FoxP3+. CD45RA can be used to further differentiate the population into naïve (CD45RA(+)) and induced (CD45RA⁻) Treg. The functional potential of Treg is routinely determined by assessing their ability to suppress T cell function in 3-5day proliferation assays. Since Treg are being explored for therapeutic use, a short-term functional assay could serve as a valuable tool for evaluating the potency of Treg. Therefore, an assay designed to measure Treg suppression of activation marker expression by responder T cells in 7 to 20h has been examined in this report. Using flow cytometry, expression of CD69 and CD154 on T cells, in response to stimulation with CD3/CD28 beads, was used as a measure of activation in the assay. Treg from healthy volunteers were sorted as CD4+CD25+CD127(lo/⁻)CD45RA+ cells with a BD FACSAria™ II. The highly purified Treg were then expanded in vitro and their function was assessed in short term activation marker suppression assays using autologous PBMC as responder cells. The data suggest that this short term suppression assay could be a reliable surrogate for assessing Treg functional potential.

摘要

人类调节性 T 细胞(Treg)能够主动抑制自身免疫反应。表型上,它们广泛表现为 CD4+、CD25+、CD127(lo/-)和 FoxP3+。CD45RA 可用于进一步将该群体分为幼稚(CD45RA(+))和诱导(CD45RA⁻)Treg。Treg 的功能潜力通常通过评估其在 3-5 天增殖测定中抑制 T 细胞功能的能力来确定。由于 Treg 正在被探索用于治疗用途,短期功能测定可以作为评估 Treg 效力的有价值工具。因此,本报告中检查了一种旨在测量 Treg 在 7 至 20 小时内抑制应答 T 细胞激活标志物表达的测定方法。通过流式细胞术,使用 CD3/CD28 珠刺激后 T 细胞上 CD69 和 CD154 的表达,作为测定中激活的衡量标准。健康志愿者的 Treg 通过 BD FACSAria™ II 作为 CD4+CD25+CD127(lo/-)CD45RA+细胞进行分选。然后,将高度纯化的 Treg 在体外扩增,并使用自体 PBMC 作为应答细胞在短期激活标志物抑制测定中评估其功能。数据表明,这种短期抑制测定可能是评估 Treg 功能潜力的可靠替代方法。

相似文献

1
Rapid assessment of in vitro expanded human regulatory T cell function.快速评估体外扩增的人调节性 T 细胞功能。
J Immunol Methods. 2011 Sep 30;372(1-2):95-106. doi: 10.1016/j.jim.2011.07.001. Epub 2011 Jul 18.
2
CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.CD39+Foxp3+调节性T细胞抑制致病性Th17细胞,且在多发性硬化症中功能受损。
J Immunol. 2009 Dec 1;183(11):7602-10. doi: 10.4049/jimmunol.0901881. Epub 2009 Nov 16.
3
CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.CD4(+)CD25(+)CD127(low/-)调节性T细胞表达Foxp3并抑制效应T细胞增殖,促进胃癌进展。
Clin Immunol. 2009 Apr;131(1):109-18. doi: 10.1016/j.clim.2008.11.010. Epub 2009 Jan 18.
4
A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy.一种用于人类调节性 T 细胞功能的快速诊断测试,以实现调节性 T 细胞治疗。
Blood. 2012 Feb 23;119(8):e57-66. doi: 10.1182/blood-2011-09-380048. Epub 2012 Jan 4.
5
Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.体外反复刺激后天然人类CD4+CD25+调节性T细胞中FOXP3表达缺失
Eur J Immunol. 2009 Apr;39(4):1088-97. doi: 10.1002/eji.200838904.
6
Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.自然杀伤细胞可阻止CD4+CD25-T淋巴细胞中CD28介导的Foxp3转录。
Exp Hematol. 2007 Mar;35(3):416-25. doi: 10.1016/j.exphem.2006.12.004.
7
CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.在异基因干细胞移植后,CD4+CD25+FOXP3+调节性T细胞在多发性骨髓瘤患者的骨髓中重建并积聚。
Haematologica. 2008 Mar;93(3):423-30. doi: 10.3324/haematol.11897. Epub 2008 Feb 20.
8
An optimized method for the functional analysis of human regulatory T cells.一种用于人类调节性T细胞功能分析的优化方法。
Scand J Immunol. 2006 Sep;64(3):353-60. doi: 10.1111/j.1365-3083.2006.01825.x.
9
CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.雷帕霉素将外周血 CD4+CD25(-) 初始 T 细胞体外诱导为 CD4+Foxp3+ 调节性 T 细胞后其体外调节能力增强。
Chin Med J (Engl). 2010 Apr 5;123(7):942-8.
10
Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.诱导共刺激分子(ICOS)是一种高抑制性抗原特异性 T 细胞的标志物,其具有 TH17/TH1 和调节性 T 细胞的特征。
J Allergy Clin Immunol. 2010 Aug;126(2):280-9, 289.e1-7. doi: 10.1016/j.jaci.2010.05.022. Epub 2010 Jul 10.

引用本文的文献

1
Short-term assays for mesenchymal stromal cell immunosuppression of T-lymphocytes.短期分析间充质基质细胞对 T 淋巴细胞的免疫抑制作用。
Front Immunol. 2023 Sep 26;14:1225047. doi: 10.3389/fimmu.2023.1225047. eCollection 2023.
2
Isolation and analysis of tumor‑derived extracellular vesicles from head and neck squamous cell carcinoma plasma by galectin‑based glycan recognition particles.基于半乳糖凝集素的糖识别颗粒从头颈鳞状细胞癌血浆中分离和分析肿瘤衍生的细胞外囊泡。
Int J Oncol. 2022 Nov;61(5). doi: 10.3892/ijo.2022.5423. Epub 2022 Sep 21.
3
Hookworm Treatment for Relapsing Multiple Sclerosis: A Randomized Double-Blinded Placebo-Controlled Trial.
钩虫治疗复发性多发性硬化症:一项随机双盲安慰剂对照试验。
JAMA Neurol. 2020 Sep 1;77(9):1089-1098. doi: 10.1001/jamaneurol.2020.1118.
4
Dawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised.(临床前)研究中监测调节性T细胞的曙光:其相关性正逐渐得到认可。
Front Med (Lausanne). 2020 Apr 2;7:91. doi: 10.3389/fmed.2020.00091. eCollection 2020.
5
Dominant TOM1 mutation associated with combined immunodeficiency and autoimmune disease.与联合免疫缺陷和自身免疫性疾病相关的显性TOM1突变。
NPJ Genom Med. 2019 Jun 27;4:14. doi: 10.1038/s41525-019-0088-5. eCollection 2019.
6
The Value of a Rapid Test of Human Regulatory T Cell Function Needs to be Revised.人类调节性 T 细胞功能的快速检测的价值需要重新评估。
Front Immunol. 2019 Feb 5;10:150. doi: 10.3389/fimmu.2019.00150. eCollection 2019.
7
Differential Roles of IL-2 Signaling in Developing versus Mature Tregs.IL-2 信号在 Treg 细胞发育和成熟中的差异作用
Cell Rep. 2018 Oct 30;25(5):1204-1213.e4. doi: 10.1016/j.celrep.2018.10.002.
8
A novel and rapid method to quantify Treg mediated suppression of CD4 T cells.一种用于定量调节性T细胞介导的对CD4 T细胞抑制作用的新颖且快速的方法。
J Immunol Methods. 2017 Oct;449:15-22. doi: 10.1016/j.jim.2017.06.009. Epub 2017 Jun 22.
9
A novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-β1 and IL-35.一种新型有效的方法,可产生高表达 IL-10、TGF-β1 和 IL-35 的人猪特异性调节性 T 细胞。
Sci Rep. 2017 Jun 21;7(1):3974. doi: 10.1038/s41598-017-04322-3.
10
Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells.肾移植中的细胞疗法:聚焦调节性T细胞
J Am Soc Nephrol. 2017 Jul;28(7):1960-1972. doi: 10.1681/ASN.2016111206. Epub 2017 May 2.